Malú Gámez Tansey

Malú Gámez Tansey

Norman and Susan Fixel Professor of Neuroscience and Neurology, Co-Director Center for Translational Research in Neurodegenerative Disease and the Parkinson’s Foundation Research Center

Department: MD-NEUROSCIENCE-GENERAL
Business Phone: (352) 294-4096
Business Email: mgtansey@ufl.edu

Publications

2020
Transgenic Mice Expressing Human α-Synuclein in Noradrenergic Neurons Develop Locus Ceruleus Pathology and Nonmotor Features of Parkinson’s Disease.
The Journal of neuroscience : the official journal of the Society for Neuroscience. 40(39):7559-7576 [DOI] 10.1523/JNEUROSCI.1468-19.2020. [PMID] 32868457.
2019
Targeting soluble tumor necrosis factor as a potential intervention to lower risk for late-onset Alzheimer’s disease associated with obesity, metabolic syndrome, and type 2 diabetes.
Alzheimer's research & therapy. 12(1) [DOI] 10.1186/s13195-019-0546-4. [PMID] 31892368.

Grants

Sep 2020 ACTIVE
Validate PFF a-syn induced inflammatory phenotype in mice.
Role: Principal Investigator
Funding: FOX FOU, MICHAEL J
Jul 2020 ACTIVE
Weston Brain Institute Grant 2020
Role: Principal Investigator
Funding: WESTON BRAIN INSTITUTE
Jun 2020 ACTIVE
Role of Gut Inflammation and Immunity on Proteostasis, Noradrenergic Degeneration and AD risk
Role: Principal Investigator
Funding: NATL INST OF HLTH NIA
May 2020 ACTIVE
Development of novel viral vectors to study and treat neuroinflammation
Role: Principal Investigator
Funding: ST JOSEPHS HOSPITAL AND MEDICAL CNTR via NATL INST OF HLTH NIA
Feb 2020 ACTIVE
The role of cannabinoid receptor 2 in inflammatory responses triggered by alpha-synuclein
Role:
Funding: FOX FOU, MICHAEL J
Dec 2019 ACTIVE
LRRK2-Synuclein Interactions with Gut Inflammation in PD Pathogenesis
Role: Principal Investigator
Funding: PARKINSONS FOU
Nov 2019 – Nov 2020
Weston Brain Institute Grant 2019
Role: Principal Investigator
Funding: WESTON BRAIN INSTITUTE
Oct 2019 – Oct 2020
Weston Brain Institute Grant
Role: Principal Investigator
Funding: WESTON BRAIN INSTITUTE
Oct 2019 ACTIVE
Study in Parkinson Disease of Exercise Phase 3 Clinical Trial: SPARX3
Role: Principal Investigator
Funding: NORTHWESTERN UNIV via NATL INST OF HLTH NINDS
Jul 2019 ACTIVE
Targeting LRRK2 in models of GI inflammation
Role: Principal Investigator
Funding: FOX FOU, MICHAEL J
May 2017 – Jun 2020
Role of HLA/MHCII in Parkinson's Disease Pathogenesis
Role: Project Manager
Funding: EMORY UNIV via NATL INST OF HLTH NINDS

Teaching Profile

Courses Taught
2019-2020
GMS6757 Introduction to Alzheimer’s Disease and Related Dementias: Clinical and Mechanistic Principles
2019
GMS7794 Neuroscience Seminar

Contact Details

Phones:
Business:
(352) 294-4096
Emails:
Business:
mgtansey@ufl.edu